Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

1.

MDS-type abnormalities within myeloma signature karyotype (MM-MDS): only 13% 1-year survival despite tandem transplants.

Jacobson J, Barlogie B, Shaughnessy J, Drach J, Tricot G, Fassas A, Zangari M, Giroux D, Crowley J, Hough A, Sawyer J.

Br J Haematol. 2003 Aug;122(3):430-40.

PMID:
12877670
[PubMed - indexed for MEDLINE]
2.

Advances in biology and therapy of multiple myeloma.

Barillé-Nion S, Barlogie B, Bataille R, Bergsagel PL, Epstein J, Fenton RG, Jacobson J, Kuehl WM, Shaughnessy J, Tricot G.

Hematology Am Soc Hematol Educ Program. 2003:248-78. Review.

PMID:
14633785
[PubMed - indexed for MEDLINE]
Free Article
3.

Chromosome 13 deletion/hypodiploidy and prognosis in multiple myeloma patients.

Fassas AB, Tricot G.

Leuk Lymphoma. 2004 Jun;45(6):1083-91. Review.

PMID:
15359986
[PubMed - indexed for MEDLINE]
4.

[Intensive treatment of multiple myeloma].

Harousseau JL.

Bull Acad Natl Med. 2003;187(2):405-13; discussion 413-5. Review. French.

PMID:
14556449
[PubMed - indexed for MEDLINE]
5.

[Biologic and clinical relevance of cytogenetic analysis in primary myelodysplastic syndromes].

Raynaud SD.

Pathol Biol (Paris). 2003 Aug;51(6):346-55. Review. French.

PMID:
12927892
[PubMed - indexed for MEDLINE]
6.

Treatment of multiple myeloma.

Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E, Walker R, Crowley J.

Blood. 2004 Jan 1;103(1):20-32. Epub 2003 Sep 11. Review.

PMID:
12969978
[PubMed - indexed for MEDLINE]
Free Article
7.

Predicting long-term survival in multiple myeloma patients following autotransplants.

Fassas AB, Van Rhee F, Tricot G.

Leuk Lymphoma. 2003 May;44(5):749-58. Review.

PMID:
12802910
[PubMed - indexed for MEDLINE]
8.

Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect.

Alyea E, Weller E, Schlossman R, Canning C, Mauch P, Ng A, Fisher D, Gribben J, Freeman A, Parikh B, Richardson P, Soiffer R, Ritz J, Anderson KC.

Bone Marrow Transplant. 2003 Dec;32(12):1145-51. Review.

PMID:
14647268
[PubMed - indexed for MEDLINE]
9.

The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple myeloma.

Johnson SK, Heuck CJ, Albino AP, Qu P, Zhang Q, Barlogie B, Shaughnessy JD Jr.

Int J Hematol. 2011 Oct;94(4):321-33. doi: 10.1007/s12185-011-0948-y. Epub 2011 Oct 15. Review.

PMID:
22002477
[PubMed - indexed for MEDLINE]
10.

New developments and treatment in multiple myeloma: new insights on molecular biology.

Drach J, Kaufmann H.

Ann Oncol. 2002;13 Suppl 4:43-7. Review. No abstract available.

PMID:
12401665
[PubMed - indexed for MEDLINE]
Free Article
11.

The use of biological variables to predict outcome in multiple myeloma.

Davies FE, Jack AS, Morgan GJ.

Br J Haematol. 1997 Dec;99(4):719-25. Review. No abstract available.

PMID:
9432013
[PubMed - indexed for MEDLINE]
12.

Prognosis in multiple myeloma.

Fonseca R, Greipp PR.

Cancer Treat Res. 1999;99:155-70. Review. No abstract available.

PMID:
9891866
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk